Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Chattem Exiting Ephedra Market With Dexatrim Reformulations

Sep 09 2002

• By The Tan Sheet

Related Content

Perrigo PPA Product Withdrawal Costs Could Reach $19 Mil.

Nov 13 2000

Kava Labeling Revisions Adopted By Trade Groups; FDA Issues Advisory

Apr 01 2002

Natrol Alternative Kava Supplement, New Labeling Debuts At Expo West

Mar 18 2002

Kava Prohibition One Of Five Options Outlined In MCA Consultation Document

Jul 29 2002

Business & Financial News In Brief

Aug 05 2002

Ephedra “Imminent Hazard” Declaration Sought By Sen. Durbin

Aug 05 2002

Metabolife Federal Probe Spurs Release Of Ephedrine Complaint Records

Aug 19 2002

Westchester County Prohibits “Conspicuous” Ephedra Store Displays

Aug 12 2002

Ephedra Product Liability Coverage Now Offered By Fewer Than 10 Insurers

Sep 09 2002

Additional Topics

OTC Drugs Consumer

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window